Xponance Inc. Raises Stock Holdings in DocuSign, Inc. (NASDAQ:DOCU)

Xponance Inc. boosted its stake in DocuSign, Inc. (NASDAQ:DOCU) by 45.8% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 51,709 shares of the company’s stock after purchasing an additional 16,249 shares during the quarter. Xponance Inc.’s holdings in DocuSign were worth $4,651,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also bought and sold shares of DOCU. Toronto Dominion Bank boosted its holdings in shares of DocuSign by 30.3% in the 3rd quarter. Toronto Dominion Bank now owns 26,159 shares of the company’s stock worth $1,624,000 after purchasing an additional 6,081 shares in the last quarter. Charles Schwab Investment Management Inc. grew its position in DocuSign by 1.2% during the third quarter. Charles Schwab Investment Management Inc. now owns 1,328,355 shares of the company’s stock valued at $82,478,000 after acquiring an additional 16,014 shares during the last quarter. Quantinno Capital Management LP grew its position in DocuSign by 39.5% during the third quarter. Quantinno Capital Management LP now owns 201,546 shares of the company’s stock valued at $12,514,000 after acquiring an additional 57,104 shares during the last quarter. Rhumbline Advisers raised its stake in shares of DocuSign by 118.8% during the fourth quarter. Rhumbline Advisers now owns 608,123 shares of the company’s stock worth $54,695,000 after acquiring an additional 330,136 shares in the last quarter. Finally, KBC Group NV raised its stake in shares of DocuSign by 32.7% during the fourth quarter. KBC Group NV now owns 1,535,107 shares of the company’s stock worth $138,067,000 after acquiring an additional 378,233 shares in the last quarter. 77.64% of the stock is currently owned by institutional investors.

DocuSign Stock Performance

DOCU stock opened at $85.11 on Friday. The company has a market capitalization of $17.19 billion, a price-to-earnings ratio of 17.55, a price-to-earnings-growth ratio of 6.94 and a beta of 1.02. The business’s 50 day moving average price is $87.58 and its two-hundred day moving average price is $79.95. DocuSign, Inc. has a fifty-two week low of $48.70 and a fifty-two week high of $107.86.

DocuSign (NASDAQ:DOCU) last issued its quarterly earnings results on Thursday, March 13th. The company reported $0.86 earnings per share for the quarter, topping the consensus estimate of $0.84 by $0.02. The company had revenue of $776.25 million for the quarter, compared to analysts’ expectations of $760.94 million. DocuSign had a return on equity of 14.90% and a net margin of 34.73%. The firm’s revenue for the quarter was up 9.0% on a year-over-year basis. During the same period in the prior year, the firm earned $0.76 earnings per share. Sell-side analysts forecast that DocuSign, Inc. will post 1.17 earnings per share for the current year.

Analysts Set New Price Targets

Several research firms recently commented on DOCU. Piper Sandler increased their target price on shares of DocuSign from $60.00 to $90.00 and gave the company a “neutral” rating in a report on Friday, December 6th. UBS Group dropped their target price on DocuSign from $100.00 to $90.00 and set a “neutral” rating for the company in a report on Friday, March 14th. Wells Fargo & Company lifted their price target on DocuSign from $70.00 to $73.00 and gave the stock an “underweight” rating in a research note on Friday, March 14th. Needham & Company LLC reissued a “hold” rating on shares of DocuSign in a report on Friday, March 14th. Finally, Hsbc Global Res upgraded shares of DocuSign to a “moderate sell” rating in a research report on Friday, December 6th. Two investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and four have given a buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $95.00.

Insider Buying and Selling

In other DocuSign news, CEO Allan C. Thygesen sold 40,000 shares of the firm’s stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $90.04, for a total transaction of $3,601,600.00. Following the completion of the transaction, the chief executive officer now owns 156,050 shares of the company’s stock, valued at approximately $14,050,742. This trade represents a 20.40 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Blake Jeffrey Grayson sold 8,000 shares of DocuSign stock in a transaction that occurred on Friday, February 14th. The shares were sold at an average price of $86.90, for a total transaction of $695,200.00. Following the transaction, the chief financial officer now owns 77,851 shares of the company’s stock, valued at $6,765,251.90. The trade was a 9.32 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 97,851 shares of company stock worth $8,579,369 in the last three months. 1.66% of the stock is owned by corporate insiders.

DocuSign Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.